222
Views
1
CrossRef citations to date
0
Altmetric
Articles

Join or be excluded from biomedicine? JOINS and Post-colonial Korea

Pages 64-74 | Received 15 Dec 2014, Accepted 04 Jan 2015, Published online: 02 Feb 2015

References

  • A Committee of Korea National Assembly on Virtual Information Values. 1999. A Public Hearing to Draft a Special Law to Promote the Development of Natural Drugs. Seoul: A Committee of Korea National Assembly on Virtual Information Values.
  • Adams, Vincanne. 2002. “Randomized Controlled Crime: Postcolonial Sciences in Alternative Medicine Research.” Social Studies of Science 32 (5/6): 659–690.
  • Cho, Byung Hee. 1988. “The State and Physicians in South Korea, 1910-1985: An Analysis of Professionalism.” PhD Thesis. Madison: University of Wisconsin.
  • Cho, Byung Hee. 2003. “Jurisdictional Conflict between Professions: The Fall and the Rise of the Acupuncturist System in the Folk Sector.” Public Health and Social Science 14: 87–126.
  • Cho, Hyo Je. 2000. “Traditional Medicine, Professional Monopoly and Structural Interests: A Korean Case.” Social Science and Medicine 50: 123–135.
  • Choi, J. H. et al. 2002. “Effects of SKI 306X, A New Herbal Agent, On Proteoglycan Degradation in Cartilage Explant Culture and Collagenase-Induced Rabbit Osteoarthritis Model.” Osteoarthritis and Cartilage 10 (6): 471–478.
  • Daston, Lorraine, ed. 1999. Biographies of Scientific Objects. Chicago/London: University of Chicago Press.
  • De Silva, Vijitha, Ashraf El-Metwally, Edzard Ernst, George Lewith, and Gary J. Macfarlane. 2011. “Evidence for the Efficacy of Complementary and Alternative Medicines in the Management of Osteoarthritis.” Rheumatology 50 (5): 911–920.
  • Institute of Natural Materials, Seoul National University. 1998. Multidisciplinary New Drugs Discovery System from Natural Products (Traditional Korean Medicinal Materials). Seoul: Ministry of Science and Technology.
  • Hayden, Cori. 2003. When Nature Goes Public: The Making and Unmaking of Bioprospecting in Mexico. Princeton: Princeton University Press.
  • Hartog, A., J. Faber, A. Sanders, C. Zuurman, H. F. Smit, P. M. van der Kraan, M. A. Hoijer, and J. Garssen. 2008. “The Multicomponent Phytophamaceutical SKI306X Inhibits in vitro Cartilage Degradation and the Production of Inflammatory Mediators.” Phytomedicine 15: 313–320.
  • Howe, Neil, Richard Jackson, and Keisuke Nakashima. 2007. The Aging of Korea: Demographics and Retirement Policy in the Land of Morning Calm. New York: Center for Strategic and International Studies.
  • Jang, Il Moo. 2001. Development of Japanese Version of Traditional Oriental Medicines Database. Seoul: Ministry of Health and Welfare.
  • Jang, Il Moo. 2011. “Cheonyeonmul Sinyak: Mwon Yeakinga?” (Natural Drugs: What Drugs Are They?) Bioin 20: 1–17.
  • Jasanoff, Sheila. 2006. “Biotechnology and Empire: The Global Power of Seeds and Science.” Osiris 21: 273–292.
  • Jung, Young-Bok et al. 2001. “Effect of SKI 306X, A New Herbal Anti-Arthritic Agent, In Patients with Osetoarthritis of the Knee: A Double-Blind Placebo Controlled Study.” American Journal of Chinese Medicine 29 (3/4): 485–491.
  • Jung, Young-Bok et al. 2004. “A Four-Week, Randomized, Double-Blind Trial of the Efficacy and Safety of SKI306X, A Herbal Antiarthritic Agent Versus Diclofenac in Osteoarthritis of the Knee.” American Journal of Chinese Medicine 32 (2): 291–301.
  • Jung, Hyung Gi. 2009. “Rheumatisseong Gwanjeongyeom Hwanjaegeseo JOINS jeonggwa Celebrex Capsulegwaui Yuhyoseong mit Naeyakseong Bigyopyeonggareul Wihan Imsang Tonggye Yeongu” (A Phase III Clinical Study of the Efficacy and Safety of JOINS Tablet in Comparison with Celebrex Treatment in Rheumatoid Arthritis Patients). Journal of Institute of Industrial Technology 23: 33–40.
  • Kim, J. H., Rhee H. I., Jung I. H., Ryu K. H., Jung K. W., Han C. K., Kwak W. J., Cho Y. B., and Joo H. J.. 2005. “SKI306X, An Oriental Herbal Mixture, Suppresses Gastric Leukotriene B4 Synthesis Without Causing Mucosal Injury and the Diclofenac-Induced Gastric Lesions.” Life Sciences 77: 1181–1193.
  • Kim, Ik Ki, Liang Jersey, Rhee Ka-Oak, and Kim Cheong-Seok. 1996. “Population Aging in Korea: Changes since the 1960s.” Journal of Cross-Cultural Gerontology 11: 369–388.
  • Kim, Jong Young. 2007. “Alternative Medicine's Encounter with Laboratory Science: The Scientific Construction of Korean Medicine in a Global Age.” Social Studies of Science 37: 855–880.
  • KIOM. 2004. Hanguk Hanuihak Yeonguwon Sipnyeonsa, 1994–2004 (A 10 Year History of KIOM, 1994–2004). Daejeon: Korea Institute of Oriental Medicine (KIOM).
  • Kuhn, S. Thomas. [1962] 1996. The Structure of Scientific Revolutions. 3rd ed. Chicago: University of Chicago Press.
  • Korea Drug Research Association (KDRA). 1992. Cheonyeonmul robuteoui Sinyak Gaebal ( Study on the Development of New Drugs from Natural Products). Seoul: Ministry of Science and Technology.
  • KDRA. 2001. Singy Saengyak Bokhapjereul Yiyonghan gwanjeongyeom Chiryoje Gaebal (Development of the New Herbal Anti Arthritis Drug (SKI 306X/ JOINS)). Seoul: Ministry of Health and Welfare.
  • Korea Food and Drug Administration. 2010. 2010nyeondo Uiyakpum Jaepyeongga ( The 2010 Report of Drugs’ Reevaluation). Seoul: Korea Food and Drug Administration.
  • Lee, Hyun Ji. 2001. Hanguk Hanuihak ui Jeonmunhwa Gwajeong e gwanhan Yeongu (A Study of the Professionalization of Korean Oriental Medicine). Ph. D. Thesis. Dept. of Sociology. Daegu, Korea: Keimyung. University.
  • Lee, Jemin. 2008. “Oriental Pharmaceutical Preparations Get Distanced from Korean Doctors.” The Minjok Medicine News, February 22.
  • Lee, S. W., Won T. C., Sun M. C., Kyung T. K., Ki S. Y., and Young H. Y. 2005. “Clematis Mandshurica Protected to Apoptosis of Rat Chondrocytes.” Journal of Ethnopharmacology 101: 294–298.
  • Lee, Tak-Sun. 2012. “Saerobge Sijange Naon Guksan Cheonyeonmul Sinyak ‘Jalnagane’ (New Natural Drugs on the Market Are ‘Highly Popular’).” DailyPharm, 25 July.
  • Lei, Sean Hsiang-lin. 1999. “From Changshan to a New Anti-Malarial Drug: Re-networking Chinese Drugs and Excluding Chinese Doctors.” Social Studies of Science 29 (3): 323–358.
  • Ma, Eunjeong. 2008. Medicine in the Making in Post-colonial Korea (1948–2006). Ph.D. Dissersation. Ithaca: Cornell University.
  • Ma, Eunjeong. 2010. “The Medicine Cabinet: Korean Medicine under Dispute.” East Asian Science, Technology, and Society 4: 367–82.
  • Mol, Annemarie. 2003. The Body Multiple: Ontology in Medical Practice. Durham: Duke University Press.
  • Oh, Se Ryang. 2011. Natural Drugs. Available online: www.bioin.or.kr. Last accessed on July 13, 2013.
  • Park, Yong Gi. 2010. “Hanuiyakgiban Uiywakpum Gaebalwi Hyeonhwanggwa Jeonmang: Hanbang Sinyak (Hanyak jeje/Saengyak jeje), Cheonyeonmul Sinyak” (The Status Quo and Prospect of Drug Development based on Herbal Medicines: Korean New Drugs (Oriental Pharmaceutical Preparations/Crude Drugs), Natural Drugs). Bioin 14: 1–15.
  • Pharmacy law. Enactment 12450, clause 2:2. Revised on 18 March, 2014. Sejong: Ministry of Health & Welfare.
  • Pordie, Laurent and Jean-Paul Gaudilliere. 2013. “The Reformulation Regime in Drug Industry: Revisiting Polyherbals and Property Rights in the Ayurvedic Industry.” East Asian Science, Technology and Society 8: 1–23.
  • Said, Edward. 1979. Orientalism. New York: Vintage Books.
  • Shin, Chang-Geon. 2007. “Institutionalization of Research on Traditional Medicine in Keijo Imperial University.” Society and History [Korean] 76: 105–139.
  • Shin, Dong Won. 2003. “Government-General of Choson's Korean Medicine Policy: Changes After the 1930s.” Korean Journal of Medical History 12 (December): 110–128.
  • SK, Ltd. 1998. “Process of Extracting and Purifying Biologically Effective Ingredients from Combined Medicinal Plants and Their Extract Composition.” European Patent Number: EP0832652A.
  • SK, Ltd. 2006. Premarket Notification for New Dietary Ingredient: Clematis Mandshurica. Washington, DC: Food and Drug Administration, pp. 73.
  • SK Chemicals. 2012. A 2012 Annual Report. Seoul: Korea. Available Online: http://www.skchemicals.com/korean/ir/pds/2012eng.pdf. Last Accessed: January 15, 2014.
  • Song, Yeong Wook et al. 2007. “Assessment of Comparative Pain Relief and Tolerability of SKI306X Compared with Celecoxib in Patients with Rheumatoid Arthritis: A 6-Week, Multicenter, Randomized, Bouble-Blind, Double-Dummy, Phase III, Noninferiority Clinical Trial.” Clinical Therapeutics 29 (5): 862–873.
  • Sung, Soo Gyung. 2011. Factors under Consideration in Developing Natural Drugs. Seoul: KFDA.
  • van der Geest, Sjaak, Susan Reynolds Whyte, and Anita Hardon. 1996. “The Anthropology of Pharmaceuticals: A Biographica Approach.” Annual Review of Anthropology 25: 153–178.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.